Jody Brooks

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

TNS Group Holdings Ltd. provides market research and information services. The firm serves various sectors including automotive, financial services, health care, packaged goods, polling and social, consumer panels, media intelligence, and television audience measurement. The company was founded by Cowling Antony Brian on June 13 1988 and is headquartered in London, United Kingdom.

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.

Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003.

Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients.

Transcrip Ltd. is a consultancy provider for biotech and pharmaceutical companies. The company is based in Wokingham, UK and has subsidiaries in Ireland. The British company offers development and commercialization services to their clients. Transcrip was founded in 2008 by Marcin Mankowski and Felicity Jane Gabbay.

Kerman & Co. LLP operates as a corporate and commercial law firm. It provides legal services related to employment, immigration, private wealth, real estate, and dispute resolution. The company was founded by Andy Kerman and Daniel O’Connell in 1998 and is headquartered in London, the United Kingdom.

VAT BRIDGE Ltd. specializing in funding VAT on commercial property purchases. The company is headquartered in Colchester, the United Kingdom.

LesterAldridge LLP provides legal services. The company's services include asset finance, banking litigation, buying and selling property, care, charities, construction, corporate and commercial, corporate banking, debt recovery, and dispute resolution. LesterAldridge is headquartered in Bournemouth, UK.

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.

MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom.

Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics.

Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage.

RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK.

Vat Bridge 7 Ltd. is a British company that provides building project development, financial intermediation, and real estate management services. Vat Bridge 7 is based in Colchester, UK. The private company was founded in 2015.

Kantar Retail UK Ltd. provides management consulting services. It offers sales and marketing consultancy services. The company was founded on May 19, 1989 and is headquartered in Epsom, the United Kingdom.

Part of Roche Holding AG, Chugai Pharma Europe Ltd. is a British pharmaceutical company that manufactures and markets pharmaceutical products. The company is based in London, UK. Chugai Pharma Europe was founded in 1997.

Phytome Life Sciences Plc is a biopharmaceutical research company, which engages in research and development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The company was founded on June 04, 2018 and is headquartered in Truro, the United Kingdom.

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.

Psych Capital Plc is an incubation and pre-seed investment company, which engages in psychedelic science and healthcare industry. It offers services through its Psych and Awakn brands. The company was founded by William Christopher Potts and Stephen Murphy on April 22, 2021 and is headquartered in London, the United Kingdom.

Part of WPP Plc, Taylor Nelson Sofres International Ltd. is a British company that offers investment companies holding services. The company is based in London, UK. Taylor Nelson Sofres International was founded in 1985.

Mazars LLP operates as an accounting firm. It specializes in audit, accountancy, advisory, tax, and legal services. The company is headquartered in London, the United Kingdom.